Maximilian Achenbach to Lead Digital Operations for Phoenix OCP in France

Maximilian Achenbach has been appointed to oversee the digital operations at Phoenix OCP, a major pharmaceutical wholesale company in France and a subsidiary of the Phoenix Group. Effective from February 2026, Achenbach joins the executive committee of Phoenix OCP, where he will drive the company's digital business initiatives in the French market.

Prior to this appointment, Achenbach played a significant role at Gesund.de, a digital health platform, where he was instrumental in shaping the platform's technology, operations, and marketing strategies. During his five-year tenure, he led the launch of an electronic prescription solution for local pharmacies and contributed to the platform's brand development and market expansion.

Before joining Gesund.de, Achenbach was responsible for leading digital commerce across Europe for the Phoenix Group. His return to Phoenix, now in a key leadership role at Phoenix OCP, marks a strategic move to enhance and expand the company's e-commerce footprint in France, which is recognized as the second-largest pharmaceutical market in Europe.

Phoenix OCP is the leading pharmaceutical wholesaler in France, with an estimated 40% market share and reported revenues of 9.5 billion euros in the 2024 fiscal year. The company's focus under Achenbach's leadership will be on advancing digital transformation and strengthening its e-commerce capabilities to meet the evolving needs of pharmacies and healthcare providers throughout France.

With this management change, the strategic and operational leadership of Gesund.de will continue under Peter Schreiner, ensuring continuity in the platform's development and service to its network of pharmacies.

This transition reflects the broader trend of digitalization within the pharmaceutical industry, particularly in key European markets. The integration of e-prescriptions and the development of digital health solutions are becoming increasingly important for wholesale distributors and local pharmacies alike, as they look to streamline operations and enhance patient care.

The move highlights Phoenix OCP's commitment to innovation and its readiness to adapt to the rapidly changing digital health landscape, positioning the company to maintain its leadership role in the French pharmaceutical sector.